nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP2D6—Hydroxyurea—head and neck cancer	0.103	0.449	CbGbCtD
Ropinirole—CYP1A2—Fluorouracil—head and neck cancer	0.0478	0.208	CbGbCtD
Ropinirole—CYP2D6—Vinblastine—head and neck cancer	0.0365	0.159	CbGbCtD
Ropinirole—DRD5—eyelid—head and neck cancer	0.034	0.253	CbGeAlD
Ropinirole—CYP3A4—Vinblastine—head and neck cancer	0.0232	0.101	CbGbCtD
Ropinirole—CYP3A4—Docetaxel—head and neck cancer	0.0191	0.0833	CbGbCtD
Ropinirole—HTR1B—trigeminal nerve—head and neck cancer	0.0154	0.114	CbGeAlD
Ropinirole—HTR1D—trigeminal nerve—head and neck cancer	0.0149	0.11	CbGeAlD
Ropinirole—HTR1B—cranial nerve—head and neck cancer	0.0109	0.0813	CbGeAlD
Ropinirole—HTR1D—cranial nerve—head and neck cancer	0.0106	0.0787	CbGeAlD
Ropinirole—HTR2A—trigeminal nerve—head and neck cancer	0.00739	0.0549	CbGeAlD
Ropinirole—HTR2A—cranial nerve—head and neck cancer	0.00526	0.0391	CbGeAlD
Ropinirole—DRD5—lymphoid tissue—head and neck cancer	0.00267	0.0198	CbGeAlD
Ropinirole—DRD3—head—head and neck cancer	0.00229	0.017	CbGeAlD
Ropinirole—HTR1D—connective tissue—head and neck cancer	0.00219	0.0162	CbGeAlD
Ropinirole—DRD5—head—head and neck cancer	0.00215	0.016	CbGeAlD
Ropinirole—ADRA2C—parotid gland—head and neck cancer	0.00182	0.0135	CbGeAlD
Ropinirole—DRD1—head—head and neck cancer	0.00164	0.0122	CbGeAlD
Ropinirole—HTR2A—neck—head and neck cancer	0.00152	0.0113	CbGeAlD
Ropinirole—HTR2B—thyroid gland—head and neck cancer	0.00135	0.01	CbGeAlD
Ropinirole—ADRA2C—trachea—head and neck cancer	0.00134	0.00998	CbGeAlD
Ropinirole—HTR1B—head—head and neck cancer	0.00133	0.00988	CbGeAlD
Ropinirole—Influenza like illness—Docetaxel—head and neck cancer	0.00132	0.00237	CcSEcCtD
Ropinirole—Haemorrhage—Hydroxyurea—head and neck cancer	0.00131	0.00236	CcSEcCtD
Ropinirole—Hallucination—Hydroxyurea—head and neck cancer	0.00131	0.00235	CcSEcCtD
Ropinirole—Colitis—Docetaxel—head and neck cancer	0.00131	0.00234	CcSEcCtD
Ropinirole—Irritability—Fluorouracil—head and neck cancer	0.00131	0.00234	CcSEcCtD
Ropinirole—Cardiac arrest—Fluorouracil—head and neck cancer	0.0013	0.00233	CcSEcCtD
Ropinirole—Candida infection—Docetaxel—head and neck cancer	0.0013	0.00233	CcSEcCtD
Ropinirole—Skin exfoliation—Docetaxel—head and neck cancer	0.0013	0.00233	CcSEcCtD
Ropinirole—Fluid retention—Docetaxel—head and neck cancer	0.00129	0.00232	CcSEcCtD
Ropinirole—HTR1D—head—head and neck cancer	0.00129	0.00957	CbGeAlD
Ropinirole—Ataxia—Fluorouracil—head and neck cancer	0.00129	0.00231	CcSEcCtD
Ropinirole—ADRA2A—connective tissue—head and neck cancer	0.00128	0.00949	CbGeAlD
Ropinirole—Neuropathy—Docetaxel—head and neck cancer	0.00128	0.00229	CcSEcCtD
Ropinirole—HTR2C—head—head and neck cancer	0.00128	0.00948	CbGeAlD
Ropinirole—Alopecia—Vinblastine—head and neck cancer	0.00127	0.00229	CcSEcCtD
Ropinirole—Dry skin—Fluorouracil—head and neck cancer	0.00125	0.00225	CcSEcCtD
Ropinirole—Oesophagitis—Docetaxel—head and neck cancer	0.00124	0.00223	CcSEcCtD
Ropinirole—Neoplasm—Docetaxel—head and neck cancer	0.00123	0.00221	CcSEcCtD
Ropinirole—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00122	0.0022	CcSEcCtD
Ropinirole—Pulmonary oedema—Docetaxel—head and neck cancer	0.00121	0.00217	CcSEcCtD
Ropinirole—Muscular weakness—Fluorouracil—head and neck cancer	0.00121	0.00217	CcSEcCtD
Ropinirole—HTR2B—head—head and neck cancer	0.0012	0.0089	CbGeAlD
Ropinirole—Angiopathy—Hydroxyurea—head and neck cancer	0.00119	0.00214	CcSEcCtD
Ropinirole—Dysphagia—Fluorouracil—head and neck cancer	0.00118	0.00212	CcSEcCtD
Ropinirole—Sepsis—Docetaxel—head and neck cancer	0.00118	0.00212	CcSEcCtD
Ropinirole—Chills—Hydroxyurea—head and neck cancer	0.00118	0.00212	CcSEcCtD
Ropinirole—Eosinophilia—Fluorouracil—head and neck cancer	0.00117	0.0021	CcSEcCtD
Ropinirole—Ill-defined disorder—Vinblastine—head and neck cancer	0.00116	0.00209	CcSEcCtD
Ropinirole—Alopecia—Hydroxyurea—head and neck cancer	0.00116	0.00209	CcSEcCtD
Ropinirole—Anaemia—Vinblastine—head and neck cancer	0.00116	0.00208	CcSEcCtD
Ropinirole—Angina pectoris—Fluorouracil—head and neck cancer	0.00115	0.00207	CcSEcCtD
Ropinirole—Phlebitis—Docetaxel—head and neck cancer	0.00115	0.00206	CcSEcCtD
Ropinirole—Thrombophlebitis—Docetaxel—head and neck cancer	0.00114	0.00205	CcSEcCtD
Ropinirole—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00113	0.00204	CcSEcCtD
Ropinirole—Malaise—Vinblastine—head and neck cancer	0.00113	0.00203	CcSEcCtD
Ropinirole—Vertigo—Vinblastine—head and neck cancer	0.00113	0.00202	CcSEcCtD
Ropinirole—Leukopenia—Vinblastine—head and neck cancer	0.00112	0.00202	CcSEcCtD
Ropinirole—Deafness—Docetaxel—head and neck cancer	0.0011	0.00198	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.0011	0.00197	CcSEcCtD
Ropinirole—Convulsion—Vinblastine—head and neck cancer	0.00109	0.00195	CcSEcCtD
Ropinirole—HTR2A—connective tissue—head and neck cancer	0.00109	0.00807	CbGeAlD
Ropinirole—Hypertension—Vinblastine—head and neck cancer	0.00108	0.00194	CcSEcCtD
Ropinirole—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00108	0.00194	CcSEcCtD
Ropinirole—HTR1A—head—head and neck cancer	0.00107	0.00798	CbGeAlD
Ropinirole—ADRA2A—trachea—head and neck cancer	0.00107	0.00797	CbGeAlD
Ropinirole—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00106	0.00191	CcSEcCtD
Ropinirole—Pneumonia—Fluorouracil—head and neck cancer	0.00106	0.0019	CcSEcCtD
Ropinirole—Anaemia—Hydroxyurea—head and neck cancer	0.00106	0.0019	CcSEcCtD
Ropinirole—Discomfort—Vinblastine—head and neck cancer	0.00106	0.00189	CcSEcCtD
Ropinirole—Hot flush—Docetaxel—head and neck cancer	0.00106	0.00189	CcSEcCtD
Ropinirole—Infestation—Fluorouracil—head and neck cancer	0.00105	0.00189	CcSEcCtD
Ropinirole—Infestation NOS—Fluorouracil—head and neck cancer	0.00105	0.00189	CcSEcCtD
Ropinirole—Menopausal symptoms—Docetaxel—head and neck cancer	0.00105	0.00188	CcSEcCtD
Ropinirole—Atrial fibrillation—Docetaxel—head and neck cancer	0.00104	0.00187	CcSEcCtD
Ropinirole—Visual disturbance—Docetaxel—head and neck cancer	0.00104	0.00187	CcSEcCtD
Ropinirole—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00104	0.00187	CcSEcCtD
Ropinirole—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00103	0.00185	CcSEcCtD
Ropinirole—Myocardial infarction—Fluorouracil—head and neck cancer	0.00103	0.00185	CcSEcCtD
Ropinirole—Dermatitis bullous—Docetaxel—head and neck cancer	0.00103	0.00185	CcSEcCtD
Ropinirole—Malaise—Hydroxyurea—head and neck cancer	0.00103	0.00185	CcSEcCtD
Ropinirole—HTR2A—epithelium—head and neck cancer	0.00103	0.00766	CbGeAlD
Ropinirole—Stomatitis—Fluorouracil—head and neck cancer	0.00103	0.00184	CcSEcCtD
Ropinirole—Urinary tract infection—Fluorouracil—head and neck cancer	0.00102	0.00184	CcSEcCtD
Ropinirole—Conjunctivitis—Fluorouracil—head and neck cancer	0.00102	0.00184	CcSEcCtD
Ropinirole—Leukopenia—Hydroxyurea—head and neck cancer	0.00102	0.00184	CcSEcCtD
Ropinirole—Cardiac failure—Docetaxel—head and neck cancer	0.00101	0.00182	CcSEcCtD
Ropinirole—Lethargy—Docetaxel—head and neck cancer	0.00101	0.00181	CcSEcCtD
Ropinirole—Thrombocytopenia—Vinblastine—head and neck cancer	0.001	0.0018	CcSEcCtD
Ropinirole—Epistaxis—Fluorouracil—head and neck cancer	0.000994	0.00178	CcSEcCtD
Ropinirole—Convulsion—Hydroxyurea—head and neck cancer	0.000991	0.00178	CcSEcCtD
Ropinirole—Hyponatraemia—Docetaxel—head and neck cancer	0.000991	0.00178	CcSEcCtD
Ropinirole—Sinusitis—Fluorouracil—head and neck cancer	0.000989	0.00178	CcSEcCtD
Ropinirole—Pain in extremity—Docetaxel—head and neck cancer	0.000987	0.00177	CcSEcCtD
Ropinirole—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000987	0.00177	CcSEcCtD
Ropinirole—Agranulocytosis—Fluorouracil—head and neck cancer	0.000983	0.00177	CcSEcCtD
Ropinirole—Anorexia—Vinblastine—head and neck cancer	0.000976	0.00175	CcSEcCtD
Ropinirole—Migraine—Docetaxel—head and neck cancer	0.000971	0.00174	CcSEcCtD
Ropinirole—DRD2—head—head and neck cancer	0.00097	0.00721	CbGeAlD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000967	0.00174	CcSEcCtD
Ropinirole—Discomfort—Hydroxyurea—head and neck cancer	0.000962	0.00173	CcSEcCtD
Ropinirole—Haemoglobin—Fluorouracil—head and neck cancer	0.000951	0.00171	CcSEcCtD
Ropinirole—Rhinitis—Fluorouracil—head and neck cancer	0.000948	0.0017	CcSEcCtD
Ropinirole—Haemorrhage—Fluorouracil—head and neck cancer	0.000946	0.0017	CcSEcCtD
Ropinirole—ADRA2C—head—head and neck cancer	0.000943	0.00701	CbGeAlD
Ropinirole—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000941	0.00169	CcSEcCtD
Ropinirole—Pharyngitis—Fluorouracil—head and neck cancer	0.000939	0.00169	CcSEcCtD
Ropinirole—Oedema—Hydroxyurea—head and neck cancer	0.000934	0.00168	CcSEcCtD
Ropinirole—Ataxia—Docetaxel—head and neck cancer	0.000928	0.00167	CcSEcCtD
Ropinirole—Infection—Hydroxyurea—head and neck cancer	0.000928	0.00167	CcSEcCtD
Ropinirole—CYP1A2—thyroid gland—head and neck cancer	0.000923	0.00685	CbGeAlD
Ropinirole—Paraesthesia—Vinblastine—head and neck cancer	0.000919	0.00165	CcSEcCtD
Ropinirole—Dehydration—Docetaxel—head and neck cancer	0.000918	0.00165	CcSEcCtD
Ropinirole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000916	0.00164	CcSEcCtD
Ropinirole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000914	0.00164	CcSEcCtD
Ropinirole—HTR2A—trachea—head and neck cancer	0.000912	0.00677	CbGeAlD
Ropinirole—Skin disorder—Hydroxyurea—head and neck cancer	0.000907	0.00163	CcSEcCtD
Ropinirole—Dry skin—Docetaxel—head and neck cancer	0.000905	0.00162	CcSEcCtD
Ropinirole—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000901	0.00162	CcSEcCtD
Ropinirole—Abdominal pain upper—Docetaxel—head and neck cancer	0.000901	0.00162	CcSEcCtD
Ropinirole—Breast disorder—Docetaxel—head and neck cancer	0.000892	0.0016	CcSEcCtD
Ropinirole—Anorexia—Hydroxyurea—head and neck cancer	0.00089	0.0016	CcSEcCtD
Ropinirole—Decreased appetite—Vinblastine—head and neck cancer	0.00089	0.0016	CcSEcCtD
Ropinirole—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000889	0.0016	CcSEcCtD
Ropinirole—Cramp muscle—Docetaxel—head and neck cancer	0.000889	0.0016	CcSEcCtD
Ropinirole—Nasopharyngitis—Docetaxel—head and neck cancer	0.000883	0.00158	CcSEcCtD
Ropinirole—Constipation—Vinblastine—head and neck cancer	0.000876	0.00157	CcSEcCtD
Ropinirole—Pain—Vinblastine—head and neck cancer	0.000876	0.00157	CcSEcCtD
Ropinirole—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00087	0.00156	CcSEcCtD
Ropinirole—Dysphagia—Docetaxel—head and neck cancer	0.000853	0.00153	CcSEcCtD
Ropinirole—ADRA2A—thyroid gland—head and neck cancer	0.000848	0.0063	CbGeAlD
Ropinirole—Arrhythmia—Fluorouracil—head and neck cancer	0.000845	0.00152	CcSEcCtD
Ropinirole—Feeling abnormal—Vinblastine—head and neck cancer	0.000844	0.00151	CcSEcCtD
Ropinirole—HTR2B—lymph node—head and neck cancer	0.000839	0.00623	CbGeAlD
Ropinirole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000837	0.0015	CcSEcCtD
Ropinirole—Alopecia—Fluorouracil—head and neck cancer	0.000836	0.0015	CcSEcCtD
Ropinirole—Dyspnoea—Hydroxyurea—head and neck cancer	0.000832	0.00149	CcSEcCtD
Ropinirole—Angina pectoris—Docetaxel—head and neck cancer	0.000831	0.00149	CcSEcCtD
Ropinirole—Somnolence—Hydroxyurea—head and neck cancer	0.00083	0.00149	CcSEcCtD
Ropinirole—Dyspepsia—Hydroxyurea—head and neck cancer	0.000822	0.00148	CcSEcCtD
Ropinirole—Decreased appetite—Hydroxyurea—head and neck cancer	0.000812	0.00146	CcSEcCtD
Ropinirole—Abdominal pain—Vinblastine—head and neck cancer	0.000809	0.00145	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000806	0.00145	CcSEcCtD
Ropinirole—Fatigue—Hydroxyurea—head and neck cancer	0.000805	0.00145	CcSEcCtD
Ropinirole—Pain—Hydroxyurea—head and neck cancer	0.000798	0.00143	CcSEcCtD
Ropinirole—Constipation—Hydroxyurea—head and neck cancer	0.000798	0.00143	CcSEcCtD
Ropinirole—Weight increased—Docetaxel—head and neck cancer	0.000776	0.00139	CcSEcCtD
Ropinirole—Vision blurred—Fluorouracil—head and neck cancer	0.000776	0.00139	CcSEcCtD
Ropinirole—Weight decreased—Docetaxel—head and neck cancer	0.000772	0.00139	CcSEcCtD
Ropinirole—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000769	0.00138	CcSEcCtD
Ropinirole—Pneumonia—Docetaxel—head and neck cancer	0.000765	0.00137	CcSEcCtD
Ropinirole—Anaemia—Fluorouracil—head and neck cancer	0.000761	0.00137	CcSEcCtD
Ropinirole—Infestation NOS—Docetaxel—head and neck cancer	0.000761	0.00137	CcSEcCtD
Ropinirole—Infestation—Docetaxel—head and neck cancer	0.000761	0.00137	CcSEcCtD
Ropinirole—Hypersensitivity—Vinblastine—head and neck cancer	0.000754	0.00135	CcSEcCtD
Ropinirole—ADRA2A—head—head and neck cancer	0.000753	0.00559	CbGeAlD
Ropinirole—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00075	0.00135	CcSEcCtD
Ropinirole—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000746	0.00134	CcSEcCtD
Ropinirole—Myocardial infarction—Docetaxel—head and neck cancer	0.000746	0.00134	CcSEcCtD
Ropinirole—Stomatitis—Docetaxel—head and neck cancer	0.000741	0.00133	CcSEcCtD
Ropinirole—Conjunctivitis—Docetaxel—head and neck cancer	0.000739	0.00133	CcSEcCtD
Ropinirole—Body temperature increased—Hydroxyurea—head and neck cancer	0.000738	0.00133	CcSEcCtD
Ropinirole—Leukopenia—Fluorouracil—head and neck cancer	0.000737	0.00132	CcSEcCtD
Ropinirole—Asthenia—Vinblastine—head and neck cancer	0.000735	0.00132	CcSEcCtD
Ropinirole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000719	0.00129	CcSEcCtD
Ropinirole—Epistaxis—Docetaxel—head and neck cancer	0.000717	0.00129	CcSEcCtD
Ropinirole—Convulsion—Fluorouracil—head and neck cancer	0.000713	0.00128	CcSEcCtD
Ropinirole—Agranulocytosis—Docetaxel—head and neck cancer	0.00071	0.00127	CcSEcCtD
Ropinirole—Chest pain—Fluorouracil—head and neck cancer	0.000701	0.00126	CcSEcCtD
Ropinirole—Myalgia—Fluorouracil—head and neck cancer	0.000701	0.00126	CcSEcCtD
Ropinirole—Diarrhoea—Vinblastine—head and neck cancer	0.000701	0.00126	CcSEcCtD
Ropinirole—Discomfort—Fluorouracil—head and neck cancer	0.000693	0.00124	CcSEcCtD
Ropinirole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000688	0.00124	CcSEcCtD
Ropinirole—Haemoglobin—Docetaxel—head and neck cancer	0.000686	0.00123	CcSEcCtD
Ropinirole—Rhinitis—Docetaxel—head and neck cancer	0.000684	0.00123	CcSEcCtD
Ropinirole—Haemorrhage—Docetaxel—head and neck cancer	0.000683	0.00123	CcSEcCtD
Ropinirole—Hypoaesthesia—Docetaxel—head and neck cancer	0.000679	0.00122	CcSEcCtD
Ropinirole—Confusional state—Fluorouracil—head and neck cancer	0.000678	0.00122	CcSEcCtD
Ropinirole—Pharyngitis—Docetaxel—head and neck cancer	0.000678	0.00122	CcSEcCtD
Ropinirole—Dizziness—Vinblastine—head and neck cancer	0.000677	0.00122	CcSEcCtD
Ropinirole—Urinary tract disorder—Docetaxel—head and neck cancer	0.000674	0.00121	CcSEcCtD
Ropinirole—Oedema peripheral—Docetaxel—head and neck cancer	0.000673	0.00121	CcSEcCtD
Ropinirole—Oedema—Fluorouracil—head and neck cancer	0.000672	0.00121	CcSEcCtD
Ropinirole—Connective tissue disorder—Docetaxel—head and neck cancer	0.000671	0.0012	CcSEcCtD
Ropinirole—Asthenia—Hydroxyurea—head and neck cancer	0.00067	0.0012	CcSEcCtD
Ropinirole—Urethral disorder—Docetaxel—head and neck cancer	0.000669	0.0012	CcSEcCtD
Ropinirole—Infection—Fluorouracil—head and neck cancer	0.000668	0.0012	CcSEcCtD
Ropinirole—ADRA2C—lymph node—head and neck cancer	0.00066	0.00491	CbGeAlD
Ropinirole—Nervous system disorder—Fluorouracil—head and neck cancer	0.000659	0.00118	CcSEcCtD
Ropinirole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000658	0.00118	CcSEcCtD
Ropinirole—Visual impairment—Docetaxel—head and neck cancer	0.000658	0.00118	CcSEcCtD
Ropinirole—Tachycardia—Fluorouracil—head and neck cancer	0.000656	0.00118	CcSEcCtD
Ropinirole—Vomiting—Vinblastine—head and neck cancer	0.000651	0.00117	CcSEcCtD
Ropinirole—Headache—Vinblastine—head and neck cancer	0.000641	0.00115	CcSEcCtD
Ropinirole—Anorexia—Fluorouracil—head and neck cancer	0.000641	0.00115	CcSEcCtD
Ropinirole—HTR2A—head—head and neck cancer	0.00064	0.00475	CbGeAlD
Ropinirole—Diarrhoea—Hydroxyurea—head and neck cancer	0.000639	0.00115	CcSEcCtD
Ropinirole—Eye disorder—Docetaxel—head and neck cancer	0.000638	0.00115	CcSEcCtD
Ropinirole—Flushing—Docetaxel—head and neck cancer	0.000634	0.00114	CcSEcCtD
Ropinirole—Cardiac disorder—Docetaxel—head and neck cancer	0.000634	0.00114	CcSEcCtD
Ropinirole—Hypotension—Fluorouracil—head and neck cancer	0.000628	0.00113	CcSEcCtD
Ropinirole—Angiopathy—Docetaxel—head and neck cancer	0.000619	0.00111	CcSEcCtD
Ropinirole—Dizziness—Hydroxyurea—head and neck cancer	0.000617	0.00111	CcSEcCtD
Ropinirole—Immune system disorder—Docetaxel—head and neck cancer	0.000617	0.00111	CcSEcCtD
Ropinirole—Mediastinal disorder—Docetaxel—head and neck cancer	0.000615	0.0011	CcSEcCtD
Ropinirole—Chills—Docetaxel—head and neck cancer	0.000613	0.0011	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000612	0.0011	CcSEcCtD
Ropinirole—Arrhythmia—Docetaxel—head and neck cancer	0.00061	0.0011	CcSEcCtD
Ropinirole—Nausea—Vinblastine—head and neck cancer	0.000608	0.00109	CcSEcCtD
Ropinirole—Insomnia—Fluorouracil—head and neck cancer	0.000608	0.00109	CcSEcCtD
Ropinirole—Paraesthesia—Fluorouracil—head and neck cancer	0.000603	0.00108	CcSEcCtD
Ropinirole—Alopecia—Docetaxel—head and neck cancer	0.000603	0.00108	CcSEcCtD
Ropinirole—Dyspnoea—Fluorouracil—head and neck cancer	0.000599	0.00108	CcSEcCtD
Ropinirole—Mental disorder—Docetaxel—head and neck cancer	0.000598	0.00107	CcSEcCtD
Ropinirole—Somnolence—Fluorouracil—head and neck cancer	0.000597	0.00107	CcSEcCtD
Ropinirole—Malnutrition—Docetaxel—head and neck cancer	0.000594	0.00107	CcSEcCtD
Ropinirole—Vomiting—Hydroxyurea—head and neck cancer	0.000594	0.00107	CcSEcCtD
Ropinirole—Dyspepsia—Fluorouracil—head and neck cancer	0.000592	0.00106	CcSEcCtD
Ropinirole—Rash—Hydroxyurea—head and neck cancer	0.000589	0.00106	CcSEcCtD
Ropinirole—Dermatitis—Hydroxyurea—head and neck cancer	0.000588	0.00106	CcSEcCtD
Ropinirole—Headache—Hydroxyurea—head and neck cancer	0.000585	0.00105	CcSEcCtD
Ropinirole—Decreased appetite—Fluorouracil—head and neck cancer	0.000584	0.00105	CcSEcCtD
Ropinirole—CYP2D6—head—head and neck cancer	0.000583	0.00433	CbGeAlD
Ropinirole—Dysgeusia—Docetaxel—head and neck cancer	0.000582	0.00105	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00058	0.00104	CcSEcCtD
Ropinirole—Back pain—Docetaxel—head and neck cancer	0.000575	0.00103	CcSEcCtD
Ropinirole—Pain—Fluorouracil—head and neck cancer	0.000575	0.00103	CcSEcCtD
Ropinirole—Muscle spasms—Docetaxel—head and neck cancer	0.000571	0.00103	CcSEcCtD
Ropinirole—Nausea—Hydroxyurea—head and neck cancer	0.000555	0.000996	CcSEcCtD
Ropinirole—Feeling abnormal—Fluorouracil—head and neck cancer	0.000554	0.000994	CcSEcCtD
Ropinirole—Anaemia—Docetaxel—head and neck cancer	0.000549	0.000986	CcSEcCtD
Ropinirole—Urticaria—Fluorouracil—head and neck cancer	0.000534	0.000959	CcSEcCtD
Ropinirole—Syncope—Docetaxel—head and neck cancer	0.000533	0.000957	CcSEcCtD
Ropinirole—Leukopenia—Docetaxel—head and neck cancer	0.000532	0.000955	CcSEcCtD
Ropinirole—Body temperature increased—Fluorouracil—head and neck cancer	0.000531	0.000954	CcSEcCtD
Ropinirole—ADRA2A—lymph node—head and neck cancer	0.000527	0.00391	CbGeAlD
Ropinirole—Palpitations—Docetaxel—head and neck cancer	0.000525	0.000943	CcSEcCtD
Ropinirole—Loss of consciousness—Docetaxel—head and neck cancer	0.000522	0.000938	CcSEcCtD
Ropinirole—Cough—Docetaxel—head and neck cancer	0.000519	0.000931	CcSEcCtD
Ropinirole—Convulsion—Docetaxel—head and neck cancer	0.000515	0.000925	CcSEcCtD
Ropinirole—Hypertension—Docetaxel—head and neck cancer	0.000513	0.000921	CcSEcCtD
Ropinirole—Chest pain—Docetaxel—head and neck cancer	0.000506	0.000909	CcSEcCtD
Ropinirole—Arthralgia—Docetaxel—head and neck cancer	0.000506	0.000909	CcSEcCtD
Ropinirole—Myalgia—Docetaxel—head and neck cancer	0.000506	0.000909	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000503	0.000902	CcSEcCtD
Ropinirole—Hypersensitivity—Fluorouracil—head and neck cancer	0.000495	0.000889	CcSEcCtD
Ropinirole—Dry mouth—Docetaxel—head and neck cancer	0.000495	0.000889	CcSEcCtD
Ropinirole—Confusional state—Docetaxel—head and neck cancer	0.000489	0.000878	CcSEcCtD
Ropinirole—Oedema—Docetaxel—head and neck cancer	0.000485	0.000871	CcSEcCtD
Ropinirole—Infection—Docetaxel—head and neck cancer	0.000482	0.000865	CcSEcCtD
Ropinirole—Shock—Docetaxel—head and neck cancer	0.000477	0.000857	CcSEcCtD
Ropinirole—Nervous system disorder—Docetaxel—head and neck cancer	0.000476	0.000854	CcSEcCtD
Ropinirole—Pruritus—Fluorouracil—head and neck cancer	0.000475	0.000854	CcSEcCtD
Ropinirole—Thrombocytopenia—Docetaxel—head and neck cancer	0.000475	0.000853	CcSEcCtD
Ropinirole—Tachycardia—Docetaxel—head and neck cancer	0.000473	0.00085	CcSEcCtD
Ropinirole—Skin disorder—Docetaxel—head and neck cancer	0.000471	0.000846	CcSEcCtD
Ropinirole—Anorexia—Docetaxel—head and neck cancer	0.000462	0.00083	CcSEcCtD
Ropinirole—Diarrhoea—Fluorouracil—head and neck cancer	0.00046	0.000826	CcSEcCtD
Ropinirole—Hypotension—Docetaxel—head and neck cancer	0.000453	0.000814	CcSEcCtD
Ropinirole—Dizziness—Fluorouracil—head and neck cancer	0.000444	0.000798	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000442	0.000794	CcSEcCtD
Ropinirole—Insomnia—Docetaxel—head and neck cancer	0.000439	0.000788	CcSEcCtD
Ropinirole—Paraesthesia—Docetaxel—head and neck cancer	0.000436	0.000782	CcSEcCtD
Ropinirole—Dyspnoea—Docetaxel—head and neck cancer	0.000432	0.000777	CcSEcCtD
Ropinirole—Somnolence—Docetaxel—head and neck cancer	0.000431	0.000774	CcSEcCtD
Ropinirole—Vomiting—Fluorouracil—head and neck cancer	0.000427	0.000767	CcSEcCtD
Ropinirole—Dyspepsia—Docetaxel—head and neck cancer	0.000427	0.000767	CcSEcCtD
Ropinirole—Rash—Fluorouracil—head and neck cancer	0.000424	0.000761	CcSEcCtD
Ropinirole—Dermatitis—Fluorouracil—head and neck cancer	0.000423	0.00076	CcSEcCtD
Ropinirole—Decreased appetite—Docetaxel—head and neck cancer	0.000422	0.000757	CcSEcCtD
Ropinirole—Headache—Fluorouracil—head and neck cancer	0.000421	0.000756	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000419	0.000752	CcSEcCtD
Ropinirole—Fatigue—Docetaxel—head and neck cancer	0.000418	0.000751	CcSEcCtD
Ropinirole—Pain—Docetaxel—head and neck cancer	0.000415	0.000745	CcSEcCtD
Ropinirole—Constipation—Docetaxel—head and neck cancer	0.000415	0.000745	CcSEcCtD
Ropinirole—Feeling abnormal—Docetaxel—head and neck cancer	0.0004	0.000718	CcSEcCtD
Ropinirole—Nausea—Fluorouracil—head and neck cancer	0.000399	0.000717	CcSEcCtD
Ropinirole—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000397	0.000712	CcSEcCtD
Ropinirole—Abdominal pain—Docetaxel—head and neck cancer	0.000383	0.000689	CcSEcCtD
Ropinirole—Body temperature increased—Docetaxel—head and neck cancer	0.000383	0.000689	CcSEcCtD
Ropinirole—Hypersensitivity—Docetaxel—head and neck cancer	0.000357	0.000642	CcSEcCtD
Ropinirole—Asthenia—Docetaxel—head and neck cancer	0.000348	0.000625	CcSEcCtD
Ropinirole—Pruritus—Docetaxel—head and neck cancer	0.000343	0.000616	CcSEcCtD
Ropinirole—Diarrhoea—Docetaxel—head and neck cancer	0.000332	0.000596	CcSEcCtD
Ropinirole—Dizziness—Docetaxel—head and neck cancer	0.000321	0.000576	CcSEcCtD
Ropinirole—Vomiting—Docetaxel—head and neck cancer	0.000308	0.000554	CcSEcCtD
Ropinirole—Rash—Docetaxel—head and neck cancer	0.000306	0.000549	CcSEcCtD
Ropinirole—Dermatitis—Docetaxel—head and neck cancer	0.000306	0.000549	CcSEcCtD
Ropinirole—Headache—Docetaxel—head and neck cancer	0.000304	0.000546	CcSEcCtD
Ropinirole—Nausea—Docetaxel—head and neck cancer	0.000288	0.000517	CcSEcCtD
Ropinirole—DRD2—Signaling Pathways—NOTCH1—head and neck cancer	2.07e-05	0.000263	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PTEN—head and neck cancer	2.04e-05	0.00026	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CCND1—head and neck cancer	2.04e-05	0.000259	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—AKT1—head and neck cancer	2.04e-05	0.000259	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.04e-05	0.000259	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NOTCH1—head and neck cancer	2.03e-05	0.000258	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—MAPK1—head and neck cancer	2.03e-05	0.000258	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—EGFR—head and neck cancer	2.03e-05	0.000258	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PTGS2—head and neck cancer	2.02e-05	0.000257	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—AKT1—head and neck cancer	2.02e-05	0.000257	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—PIK3CA—head and neck cancer	2e-05	0.000255	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PTEN—head and neck cancer	2e-05	0.000254	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL2—head and neck cancer	2e-05	0.000254	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—PIK3CA—head and neck cancer	1.99e-05	0.000253	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—AKT1—head and neck cancer	1.99e-05	0.000253	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PTEN—head and neck cancer	1.97e-05	0.00025	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—HRAS—head and neck cancer	1.96e-05	0.000249	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—AKT1—head and neck cancer	1.95e-05	0.000248	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CCND1—head and neck cancer	1.95e-05	0.000248	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—PIK3CA—head and neck cancer	1.94e-05	0.000247	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	1.94e-05	0.000246	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—HRAS—head and neck cancer	1.93e-05	0.000246	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—TYMS—head and neck cancer	1.92e-05	0.000244	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—AKT1—head and neck cancer	1.92e-05	0.000244	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	1.91e-05	0.000242	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—AKT1—head and neck cancer	1.9e-05	0.000242	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.9e-05	0.000241	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—PIK3CA—head and neck cancer	1.89e-05	0.00024	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL2—head and neck cancer	1.88e-05	0.000239	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—PIK3CA—head and neck cancer	1.88e-05	0.000239	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PTEN—head and neck cancer	1.88e-05	0.000239	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—AKT1—head and neck cancer	1.88e-05	0.000239	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL2—head and neck cancer	1.86e-05	0.000236	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	1.85e-05	0.000235	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—VEGFA—head and neck cancer	1.85e-05	0.000235	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	1.84e-05	0.000234	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—EGFR—head and neck cancer	1.84e-05	0.000234	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CCND1—head and neck cancer	1.84e-05	0.000233	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—AKT1—head and neck cancer	1.83e-05	0.000233	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—STAT3—head and neck cancer	1.83e-05	0.000232	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TP53—head and neck cancer	1.82e-05	0.000231	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	1.82e-05	0.000231	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GPX1—head and neck cancer	1.82e-05	0.000231	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	1.81e-05	0.00023	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CCND1—head and neck cancer	1.81e-05	0.00023	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	1.81e-05	0.00023	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	1.81e-05	0.00023	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—VEGFA—head and neck cancer	1.81e-05	0.00023	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.8e-05	0.000229	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—STAT3—head and neck cancer	1.79e-05	0.000227	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—VEGFA—head and neck cancer	1.78e-05	0.000226	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.78e-05	0.000226	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PTEN—head and neck cancer	1.77e-05	0.000225	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PTEN—head and neck cancer	1.76e-05	0.000224	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—PIK3CA—head and neck cancer	1.76e-05	0.000224	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—STAT3—head and neck cancer	1.76e-05	0.000224	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	1.76e-05	0.000224	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PTEN—head and neck cancer	1.75e-05	0.000222	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MAPK3—head and neck cancer	1.75e-05	0.000222	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—HRAS—head and neck cancer	1.75e-05	0.000222	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—HRAS—head and neck cancer	1.74e-05	0.000221	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	1.73e-05	0.00022	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.73e-05	0.00022	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—AKT1—head and neck cancer	1.73e-05	0.00022	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MAPK3—head and neck cancer	1.71e-05	0.000217	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—AKT1—head and neck cancer	1.71e-05	0.000217	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	1.7e-05	0.000216	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—AKT1—head and neck cancer	1.7e-05	0.000216	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	1.68e-05	0.000214	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MAPK3—head and neck cancer	1.68e-05	0.000214	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—STAT3—head and neck cancer	1.68e-05	0.000214	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL2—head and neck cancer	1.68e-05	0.000213	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	1.68e-05	0.000213	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MAPK1—head and neck cancer	1.66e-05	0.000211	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EGFR—head and neck cancer	1.66e-05	0.000211	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	1.65e-05	0.00021	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	1.65e-05	0.00021	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—head and neck cancer	1.64e-05	0.000209	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	1.64e-05	0.000208	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCND1—head and neck cancer	1.64e-05	0.000208	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—HRAS—head and neck cancer	1.63e-05	0.000207	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	1.63e-05	0.000207	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—TYMS—head and neck cancer	1.63e-05	0.000207	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MAPK1—head and neck cancer	1.63e-05	0.000207	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EGFR—head and neck cancer	1.63e-05	0.000207	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL2—head and neck cancer	1.62e-05	0.000206	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL2—head and neck cancer	1.61e-05	0.000205	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.61e-05	0.000204	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	1.61e-05	0.000204	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—head and neck cancer	1.6e-05	0.000203	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MAPK1—head and neck cancer	1.6e-05	0.000203	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EGFR—head and neck cancer	1.6e-05	0.000203	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	1.6e-05	0.000203	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—STAT3—head and neck cancer	1.59e-05	0.000201	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AKT1—head and neck cancer	1.58e-05	0.000201	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—head and neck cancer	1.58e-05	0.000201	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCND1—head and neck cancer	1.58e-05	0.000201	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PTEN—head and neck cancer	1.58e-05	0.000201	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.58e-05	0.0002	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.57e-05	0.0002	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCND1—head and neck cancer	1.57e-05	0.0002	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL2—head and neck cancer	1.57e-05	0.000199	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—STAT3—head and neck cancer	1.56e-05	0.000199	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GPX1—head and neck cancer	1.54e-05	0.000196	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AKT1—head and neck cancer	1.54e-05	0.000196	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKT1—head and neck cancer	1.54e-05	0.000195	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCND1—head and neck cancer	1.53e-05	0.000194	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	1.53e-05	0.000194	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—head and neck cancer	1.53e-05	0.000194	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.53e-05	0.000194	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PTEN—head and neck cancer	1.52e-05	0.000194	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PTEN—head and neck cancer	1.52e-05	0.000193	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK3—head and neck cancer	1.51e-05	0.000192	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK3—head and neck cancer	1.49e-05	0.00019	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	1.49e-05	0.000189	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	1.48e-05	0.000188	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HRAS—head and neck cancer	1.48e-05	0.000188	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTEN—head and neck cancer	1.48e-05	0.000187	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	1.46e-05	0.000185	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PIK3CA—head and neck cancer	1.44e-05	0.000183	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK1—head and neck cancer	1.44e-05	0.000183	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—head and neck cancer	1.44e-05	0.000183	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—head and neck cancer	1.44e-05	0.000183	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	1.44e-05	0.000183	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTEN—head and neck cancer	1.43e-05	0.000182	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.43e-05	0.000182	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—head and neck cancer	1.43e-05	0.000181	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2—head and neck cancer	1.42e-05	0.000181	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK1—head and neck cancer	1.42e-05	0.000181	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—head and neck cancer	1.42e-05	0.000181	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	1.42e-05	0.00018	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—head and neck cancer	1.41e-05	0.000179	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PIK3CA—head and neck cancer	1.41e-05	0.000179	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2—head and neck cancer	1.4e-05	0.000178	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—head and neck cancer	1.39e-05	0.000177	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PIK3CA—head and neck cancer	1.39e-05	0.000177	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCND1—head and neck cancer	1.39e-05	0.000176	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	1.38e-05	0.000175	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	1.37e-05	0.000174	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—head and neck cancer	1.37e-05	0.000174	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCND1—head and neck cancer	1.36e-05	0.000173	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—head and neck cancer	1.36e-05	0.000173	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—head and neck cancer	1.36e-05	0.000172	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK3—head and neck cancer	1.35e-05	0.000171	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—head and neck cancer	1.34e-05	0.000171	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTEN—head and neck cancer	1.34e-05	0.00017	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HRAS—head and neck cancer	1.33e-05	0.00017	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—head and neck cancer	1.33e-05	0.000169	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	1.33e-05	0.000169	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	1.32e-05	0.000168	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—head and neck cancer	1.32e-05	0.000168	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTEN—head and neck cancer	1.32e-05	0.000167	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HRAS—head and neck cancer	1.31e-05	0.000166	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—head and neck cancer	1.31e-05	0.000166	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	1.3e-05	0.000166	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	1.3e-05	0.000165	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	1.29e-05	0.000164	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HRAS—head and neck cancer	1.29e-05	0.000163	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	1.28e-05	0.000163	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK1—head and neck cancer	1.28e-05	0.000163	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—head and neck cancer	1.28e-05	0.000163	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—head and neck cancer	1.28e-05	0.000163	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2—head and neck cancer	1.27e-05	0.000162	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK3—head and neck cancer	1.26e-05	0.00016	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TYMS—head and neck cancer	1.26e-05	0.00016	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.25e-05	0.000159	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PIK3CA—head and neck cancer	1.25e-05	0.000159	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PIK3CA—head and neck cancer	1.24e-05	0.000158	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.24e-05	0.000158	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	1.24e-05	0.000158	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	1.24e-05	0.000158	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—head and neck cancer	1.24e-05	0.000157	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PIK3CA—head and neck cancer	1.23e-05	0.000157	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	1.23e-05	0.000157	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—head and neck cancer	1.23e-05	0.000157	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HRAS—head and neck cancer	1.23e-05	0.000156	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—head and neck cancer	1.21e-05	0.000154	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—head and neck cancer	1.21e-05	0.000154	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK1—head and neck cancer	1.2e-05	0.000152	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—head and neck cancer	1.2e-05	0.000152	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	1.2e-05	0.000152	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—head and neck cancer	1.2e-05	0.000152	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—head and neck cancer	1.19e-05	0.000152	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	1.19e-05	0.000151	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GPX1—head and neck cancer	1.19e-05	0.000151	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—head and neck cancer	1.18e-05	0.00015	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—head and neck cancer	1.18e-05	0.00015	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.18e-05	0.00015	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	1.17e-05	0.000149	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HRAS—head and neck cancer	1.16e-05	0.000147	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—head and neck cancer	1.15e-05	0.000147	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK3—head and neck cancer	1.14e-05	0.000145	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HRAS—head and neck cancer	1.14e-05	0.000145	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—head and neck cancer	1.14e-05	0.000144	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	1.13e-05	0.000143	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PIK3CA—head and neck cancer	1.11e-05	0.000142	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK1—head and neck cancer	1.09e-05	0.000138	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—head and neck cancer	1.09e-05	0.000138	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—head and neck cancer	1.08e-05	0.000138	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	1.08e-05	0.000138	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—head and neck cancer	1.08e-05	0.000137	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	1.08e-05	0.000137	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	1.07e-05	0.000136	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	1.07e-05	0.000136	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.07e-05	0.000136	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—head and neck cancer	1.07e-05	0.000136	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	1.07e-05	0.000136	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CA—head and neck cancer	1.04e-05	0.000132	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—head and neck cancer	1.04e-05	0.000132	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—head and neck cancer	1.04e-05	0.000132	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HRAS—head and neck cancer	1.03e-05	0.000131	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	1.02e-05	0.00013	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—head and neck cancer	1.02e-05	0.00013	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—head and neck cancer	1.02e-05	0.000129	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CA—head and neck cancer	1.01e-05	0.000128	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—head and neck cancer	1.01e-05	0.000128	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—head and neck cancer	1.01e-05	0.000128	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HRAS—head and neck cancer	9.95e-06	0.000126	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HRAS—head and neck cancer	9.9e-06	0.000126	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	9.74e-06	0.000124	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	9.74e-06	0.000124	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HRAS—head and neck cancer	9.63e-06	0.000122	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	9.44e-06	0.00012	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTEN—head and neck cancer	9.34e-06	0.000119	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	9.29e-06	0.000118	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—head and neck cancer	9.14e-06	0.000116	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—head and neck cancer	9.1e-06	0.000116	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—head and neck cancer	9.07e-06	0.000115	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—head and neck cancer	8.99e-06	0.000114	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—head and neck cancer	8.79e-06	0.000112	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—head and neck cancer	8.74e-06	0.000111	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HRAS—head and neck cancer	8.74e-06	0.000111	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HRAS—head and neck cancer	8.6e-06	0.000109	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—head and neck cancer	8.5e-06	0.000108	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	8.45e-06	0.000107	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—head and neck cancer	8.26e-06	0.000105	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—head and neck cancer	8.18e-06	0.000104	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTEN—head and neck cancer	7.91e-06	0.000101	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	7.82e-06	9.94e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—head and neck cancer	7.71e-06	9.8e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—head and neck cancer	7.59e-06	9.65e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—head and neck cancer	7e-06	8.9e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	6.91e-06	8.78e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CA—head and neck cancer	6.59e-06	8.37e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTEN—head and neck cancer	6.11e-06	7.76e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CA—head and neck cancer	5.58e-06	7.09e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—head and neck cancer	5.38e-06	6.84e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—head and neck cancer	4.56e-06	5.79e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.31e-06	5.47e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—head and neck cancer	3.52e-06	4.47e-05	CbGpPWpGaD
